Date published: 2026-1-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn2r54 Activators

Chemical activators of Vmn2r54 can influence its activity through various mechanisms, primarily involving the cAMP-dependent signaling pathway. Cyclic AMP itself is a central molecule in this pathway, directly activating protein kinase A (PKA), which can phosphorylate and thus activate Vmn2r54. Forskolin, a diterpene, serves as an activator of adenylate cyclase, which catalyzes the conversion of ATP to cAMP. The increased cAMP levels subsequently activate PKA, which is known to phosphorylate target proteins like Vmn2r54. Similarly, isoproterenol, a synthetic catecholamine, engages beta-adrenergic receptors, leading to elevated intracellular cAMP and PKA activation, which in turn can activate Vmn2r54. Epinephrine, a natural catecholamine, binds to adrenergic receptors and performs a similar function, enhancing cAMP levels, thereby activating PKA and Vmn2r54. Histamine, through its action on H2 receptors, and glucagon, via its own receptor, both raise cAMP levels, further influencing PKA activity and the activation potential of Vmn2r54.

Additional chemical activators include IBMX, rolipram, cilostamide, vinpocetine, anagrelide, and alprostadil, which all elevate cAMP concentrations through inhibition of various phosphodiesterases (PDEs) or direct stimulation of adenylate cyclase. IBMX is a non-selective phosphodiesterase inhibitor, which prevents the breakdown of cAMP, thus indirectly contributing to the activation of PKA and Vmn2r54. Rolipram selectively inhibits PDE4, cilostamide targets PDE3, and vinpocetine inhibits PDE1, each leading to an increase in cAMP levels and enhanced activation of PKA, which can then phosphorylate and activate Vmn2r54. Anagrelide, another inhibitor of PDE3, increases cAMP levels, activating PKA, and subsequently Vmn2r54. Alprostadil directly stimulates adenylate cyclase, leading to an increase in the production of cAMP, again resulting in PKA activation and the phosphorylation of Vmn2r54, thereby activating the protein. These chemicals operate through a shared pathway that culminates in the functional activation of Vmn2r54, demonstrating the interconnected nature of cellular signaling mechanisms and their effect on specific proteins.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Adenosine 3′,5′-cyclic monophosphate

60-92-4sc-217584
sc-217584A
sc-217584B
sc-217584C
sc-217584D
sc-217584E
100 mg
250 mg
5 g
10 g
25 g
50 g
$116.00
$179.00
$265.00
$369.00
$629.00
$1150.00
(1)

Cyclic AMP directly activates protein kinase A (PKA), which can phosphorylate and activate Vmn2r54 as part of the cAMP-dependent signaling pathway.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol, through beta-adrenergic receptors, increases cAMP thus activating PKA, and subsequently Vmn2r54.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Epinephrine binds to adrenergic receptors, elevating cAMP and activating PKA, which then can activate Vmn2r54.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$94.00
$283.00
$988.00
7
(1)

Histamine, via H2 receptors, increases intracellular cAMP, leading to PKA activation and subsequent activation of Vmn2r54.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX inhibits phosphodiesterases, elevating cAMP levels, which enhances PKA activity and leads to the activation of Vmn2r54.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram selectively inhibits phosphodiesterase-4, increasing cAMP levels, thereby activating PKA and Vmn2r54 in turn.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$92.00
$357.00
16
(1)

Cilostamide, by inhibiting phosphodiesterase-3, raises cAMP concentrations, which activates PKA and thus Vmn2r54.

Vinpocetine

42971-09-5sc-201204
sc-201204A
sc-201204B
20 mg
100 mg
15 g
$55.00
$214.00
$2400.00
4
(1)

Vinpocetine inhibits phosphodiesterase-1, increasing cAMP levels, leading to PKA activation and subsequent activation of Vmn2r54.

Anagrelide

68475-42-3sc-491875
25 mg
$150.00
(0)

Anagrelide inhibits phosphodiesterase-3, increasing cAMP levels, which leads to activation of PKA and potentially Vmn2r54.

PGE1 (Prostaglandin E1)

745-65-3sc-201223
sc-201223A
1 mg
10 mg
$31.00
$145.00
16
(4)

Alprostadil directly stimulates adenylate cyclase, which increases cAMP levels, leading to PKA activation and subsequent activation of Vmn2r54.